An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET

被引:46
作者
Hofheinz, Frank [1 ]
Buetof, Rebecca [2 ,3 ]
Apostolova, Ivayla [4 ]
Zoephel, Klaus [3 ,5 ]
Steffen, Ingo G. [4 ]
Amthauer, Holger [4 ]
Kotzerke, Joerg [1 ,5 ]
Baumann, Michael [2 ,3 ,6 ,7 ,8 ]
van den Hoff, Joerg [1 ,5 ]
机构
[1] Helmholtz Zentrum Dresden Rossendorf, PET Ctr, Inst Radiopharmaceut Canc Res, Bautzner Landstr, Dresden, Germany
[2] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Radiat Oncol, D-01062 Dresden, Germany
[3] OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany
[4] Univ Klinikum Magdeburg AoR, Klin Radiol & Nukl Med, Magdeburg, Germany
[5] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Nucl Med, D-01062 Dresden, Germany
[6] German Canc Consortium DKTK, Dresden, Germany
[7] German Canc Res Ctr, Heidelberg, Germany
[8] Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol, Dresden, Germany
来源
EJNMMI RESEARCH | 2016年 / 6卷
关键词
PET; FDG; Tumor-to-blood ratio; SUR; Tumor-to-liver ratio; TLR; POSITRON-EMISSION-TOMOGRAPHY; GLUCOSE-METABOLISM; UPTAKE VALUES; BODY-WEIGHT; QUANTIFICATION; PARAMETER; SUPERIOR;
D O I
10.1186/s13550-016-0174-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The standardized uptake value (SUV) is the nearly exclusive means for quantitative evaluation of clinical [18F-]fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) whole body investigations. However, the SUV methodology has well-known shortcomings. In this context, it has been recognized that at least part of the problems can be eliminated if tumor SUV is normalized to the SUV of a reference region in the liver (tumor-to-liver [TLR] ratio). In recent publications, we have systematically investigated the tumor-to-blood SUV ratio (SUR) for normalization of tumor SUVs which in our view offers principal advantages in comparison to TLR. The aim of this study was a comprehensive comparison of TLR and SUR in terms of quantification of tumor lesions. Methods: 18F-FDG PET/CT was performed in 424 patients (557 scans) with different tumor entities prior to radio(chemo) therapy. In the PET images, SUVmax of the primary tumor was determined. SUVliver was calculated in the inferior right lobe of the liver. SUVblood was determined by manually delineating the aorta in the low-dose CT. TLR and SUR were computed and scan time corrected to 60 min p.i. (TLRtc and SURtc). Correlation analysis was performed for SUVliver vs. SUVblood, TLR vs. SUR, SUVliver/SUVblood vs. SUVblood, SURtc/TLR vs. SURtc, and SURtc/TLRtc vs. SURtc. Variability of the respective ratios was assessed via histogram analysis. The prognostic value of TLR and TLRtc for distant metastases-free survival (DM) was investigated with univariate Cox regression in a homogeneous subgroup (N = 130) and compared to previously published results for SUV and SURtc. Results: Correlation analysis revealed a linear correlation of SUVliver vs. SUVblood (R-2 = 0.83) and of TLR vs. SURtc (R-2 = 0.92). The SUVliver/SUVblood ratio (mean +/- s.d.) was 1.47 +/- 0.18. For the SURtc/TLR ratio, we obtained 1.14 +/- 0.21 and for the SURtc/TLRtc ratio 1.38 +/- 0.17. Survival analysis revealed TLR and TLRtc as significant prognostic factors for DM (hazard ratio [HR] = 3.3 and HR = 3, respectively). Both hazard ratios are lower than that of SURtc (HR = 4.1) although this reduction does not reach statistical significance for the given limited group size. HRs of TLR and SURtc are both significantly higher than HR of SUV (HR = 2.2). Conclusions: Suitability of the liver as surrogate of arterial tracer supply for SUV normalization via TLR computation is limited. Further studies in sufficiently large patient groups are required to better characterize the relative performance of SUV, TLR, and SUR in different settings.
引用
收藏
页数:9
相关论文
共 28 条
[1]   Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC [J].
Bahce, I. ;
Vos, C. G. ;
Dickhoff, C. ;
Hartemink, K. J. ;
Dahele, M. ;
Smit, E. F. ;
Boellaard, R. ;
Hoekstra, O. S. ;
Thunnissen, E. .
LUNG CANCER, 2014, 85 (02) :205-212
[2]   F-18 FLUORODEOXYGLUCOSE PET IN-VIVO EVALUATION OF PANCREATIC GLUCOSE-METABOLISM FOR DETECTION OF PANCREATIC-CANCER [J].
BARES, R ;
KLEVER, P ;
HAUPTMANN, S ;
HELLWIG, D ;
FASS, J ;
CREMERIUS, U ;
SCHUMPELICK, V ;
MITTERMAYER, C ;
BULL, U .
RADIOLOGY, 1994, 192 (01) :79-86
[3]   Variations in Clinical PET/CT Operations: Results of an International Survey of Active PET/CT Users [J].
Beyer, Thomas ;
Czernin, Johannes ;
Freudenberg, Lutz S. .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (02) :303-310
[4]   Reference Range for Intrapatient Variability in Blood-Pool and Liver SUV for 18F-FDG PET [J].
Boktor, Raef R. ;
Walker, Gregory ;
Stacey, Roderick ;
Gledhill, Samuel ;
Pitman, Alexander G. .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) :677-682
[5]   Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma [J].
Buetof, Rebecca ;
Hofheinz, Frank ;
Zoephel, Klaus ;
Stadelmann, Tobias ;
Schmollack, Julia ;
Jentsch, Christina ;
Loeck, Steffen ;
Kotzerke, Joerg ;
Baumann, Michael ;
van den Hoff, Joerg .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (08) :1150-1156
[6]   18F-FDG Uptake Changes in Liver and Mediastinum During Chemotherapy in Patients With Diffuse Large B-cell Lymphoma [J].
Ceriani, Luca ;
Suriano, Sergio ;
Ruberto, Teresa ;
Zucca, Emanuele ;
Giovanella, Luca .
CLINICAL NUCLEAR MEDICINE, 2012, 37 (10) :949-952
[7]   Evaluation of benign vs malignant hepatic lesions with positron emission tomography [J].
Delbeke, D ;
Martin, WH ;
Sandler, MP ;
Chapman, WC ;
Wright, JK ;
Pinson, CW .
ARCHIVES OF SURGERY, 1998, 133 (05) :510-515
[8]   Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer [J].
Flamen, P ;
Van Cutsem, E ;
Lerut, A ;
Cambier, JP ;
Haustermans, K ;
Bormans, G ;
De Leyn, P ;
Van Raemdonck, D ;
De Wever, W ;
Ectors, N ;
Maes, A ;
Mortelmans, L .
ANNALS OF ONCOLOGY, 2002, 13 (03) :361-368
[9]  
HAMBERG LM, 1994, J NUCL MED, V35, P1308
[10]   Automatic volume delineation in oncological PET Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets [J].
Hofheinz, F. ;
Poetzsch, C. ;
Oehme, L. ;
Beuthien-Baumann, B. ;
Steinbach, J. ;
Kotzerke, J. ;
van den Hoff, J. .
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2012, 51 (01) :9-16